Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Sep;71(3):235–238. doi: 10.1136/adc.71.3.235

Osteopenia in cerebral palsy.

N J Shaw 1, C P White 1, W D Fraser 1, L Rosenbloom 1
PMCID: PMC1029978  PMID: 7979497

Abstract

The bone mineral density of the lumbar spine was assessed in nine non-ambulant children with cerebral palsy combined with measurements of serum 25-hydroxyvitamin D, parathyroid hormone, and urinary calcium excretion. Three children with recurrent fractures received treatment with bisphosphonates for periods ranging from 12-18 months. All the children demonstrated a severe reduction in bone mineral density even when allowance was made for their body weight. There were no consistent abnormalities of vitamin D or parathyroid hormone status. Three children had gross hypercalciuria. Each of the children treated with bisphosphonates demonstrated an increment in bone density ranging from 20-40% with no apparent adverse effects.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carter D. R., Bouxsein M. L., Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992 Feb;7(2):137–145. doi: 10.1002/jbmr.5650070204. [DOI] [PubMed] [Google Scholar]
  2. Davie M. W., Haddaway M. J. Bone mineral content and density in healthy subjects and in osteogenesis imperfecta. Arch Dis Child. 1994 Apr;70(4):331–334. doi: 10.1136/adc.70.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dent C. E., Richens A., Rowe D. J., Stamp T. C. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J. 1970 Oct 10;4(5727):69–72. doi: 10.1136/bmj.4.5727.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hahn T. J. Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab. 1980 Mar;9(1):107–127. doi: 10.1016/s0300-595x(80)80023-5. [DOI] [PubMed] [Google Scholar]
  5. Kruse K. On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism. Eur J Pediatr. 1982 May;138(3):202–205. doi: 10.1007/BF00441202. [DOI] [PubMed] [Google Scholar]
  6. Mazess R. B., Whedon G. D. Immobilization and bone. Calcif Tissue Int. 1983 May;35(3):265–267. doi: 10.1007/BF02405043. [DOI] [PubMed] [Google Scholar]
  7. McCloskey E. V., Yates A. J., Gray R. E., Hamdy N. A., Galloway J., Kanis J. A. Diphosphonates and phosphate homoeostasis in man. Clin Sci (Lond) 1988 Jun;74(6):607–612. doi: 10.1042/cs0740607. [DOI] [PubMed] [Google Scholar]
  8. Nagant de Deuxchaisnes C., Rombouts-Lindemans C., Huaux J. P., Devogelaer J. P. Diphosphonates and inhibition of bone mineralization. Lancet. 1982 Sep 11;2(8298):607–608. doi: 10.1016/s0140-6736(82)90681-x. [DOI] [PubMed] [Google Scholar]
  9. Rosenstein B. D., Greene W. B., Herrington R. T., Blum A. S. Bone density in myelomeningocele: the effects of ambulatory status and other factors. Dev Med Child Neurol. 1987 Aug;29(4):486–494. doi: 10.1111/j.1469-8749.1987.tb02508.x. [DOI] [PubMed] [Google Scholar]
  10. Shaw N. J., Wheeldon J., Brocklebank J. T. Indices of intact serum parathyroid hormone and renal excretion of calcium, phosphate, and magnesium. Arch Dis Child. 1990 Nov;65(11):1208–1211. doi: 10.1136/adc.65.11.1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Slemenda C. W., Miller J. Z., Hui S. L., Reister T. K., Johnston C. C., Jr Role of physical activity in the development of skeletal mass in children. J Bone Miner Res. 1991 Nov;6(11):1227–1233. doi: 10.1002/jbmr.5650061113. [DOI] [PubMed] [Google Scholar]
  12. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES